Madrigal Pharmaceuticals Inc

NAS:MDGLHealthcareNASDAQ:NBINASDAQ:NQUSMG

$447.09−0.59%At closeAt close · Tue 20 Oct · ≈ AED 1,641.94 · Market cap $10.33B · Next earnings Thu 29 Oct

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.1	0.0	0.3	0.1	0.1	0.2	+98.7%
Cash & short-term investments	0.3	0.3	0.4	0.6	0.9	1.0	+6.2%
Receivables	0.0	0.0	0.0	0.0	0.1	0.1	+149.9%
Inventory	0.0	0.0	0.0	0.0	0.0	0.1	+119.7%
Total current assets	0.3	0.3	0.4	0.6	1.0	1.2	+20.6%
Property, plant & equipment	0.0	0.0	0.0	0.0	0.0	0.0	+40.2%
Goodwill & intangibles	0.0	0.0	0.0	0.0	0.0	0.0	+56.1%
Long-term investments	0.0	0.0	0.0	0.0	0.0	0.0	—
Total assets	0.3	0.3	0.4	0.6	1.0	1.3	+20.9%
Payables	0.0	0.0	0.0	0.0	0.0	0.0	+12.1%
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	—
Total current liabilities	0.0	0.1	0.1	0.1	0.2	0.3	+83.3%
Long-term debt	0.0	0.0	0.0	0.1	0.1	0.3	+194.8%
Total debt	0.0	0.0	0.0	0.1	0.1	0.4	+196.4%
Net debt	(0.1)	(0.0)	(0.3)	0.0	0.0	0.2	+696.2%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	—
Total liabilities	0.0	0.1	0.2	0.2	0.3	0.7	+128.2%
Total equity	0.2	0.2	0.2	0.4	0.8	0.6	−20.1%
Retained earnings	(0.4)	(0.7)	(1.0)	(1.3)	(1.8)	(2.1)	−16.0%

USD billionsUpdated Thu 30 Jul ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.